Histopathologic variability in usual and nonspecific interstitial pneumonias.

PubWeight™: 4.01‹?› | Rank: Top 1%

🔗 View Article (PMID 11719316)

Published in Am J Respir Crit Care Med on November 01, 2001

Authors

K R Flaherty1, W D Travis, T V Colby, G B Toews, E A Kazerooni, B H Gross, A Jain, R L Strawderman, A Flint, J P Lynch, F J Martinez

Author Affiliations

1: Department of Radiology, University of Michigan Health System, University of Michigan School of Public Health, Ann Arbor, Michigan 48109-0360, USA.

Articles citing this

Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71

Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med (2005) 4.25

Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med (2005) 3.72

Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med (2006) 3.32

Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54

Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax (2004) 2.45

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 2.43

Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc (2006) 2.40

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med (2006) 2.37

WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol (2009) 2.36

Idiopathic pulmonary fibrosis. Orphanet J Rare Dis (2008) 2.34

Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol (2003) 2.20

Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 2.20

Pulmonary fibrosis: patterns and perpetrators. J Clin Invest (2012) 2.05

Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94

Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem (2008) 1.69

The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal (2008) 1.60

Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest (2009) 1.56

Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation. Thorax (2007) 1.51

Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis. Clin Immunol (2011) 1.39

Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology (2011) 1.32

Animal models of fibrotic lung disease. Am J Respir Cell Mol Biol (2013) 1.31

Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax (2004) 1.29

Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. Am J Respir Crit Care Med (2007) 1.29

Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am J Pathol (2011) 1.27

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair (2011) 1.23

Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol (2004) 1.20

Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function. J Korean Med Sci (2009) 1.04

CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir Res (2005) 1.04

Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest (2009) 1.03

Molecular magnetic resonance imaging of pulmonary fibrosis in mice. Am J Respir Cell Mol Biol (2013) 0.99

The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms. Am J Pathol (2009) 0.99

Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia. J Clin Pathol (2004) 0.99

Transbronchial biopsy is useful in predicting UIP pattern. Respir Res (2012) 0.97

TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem Cell Biol (2008) 0.96

A novel method for accurate collagen and biochemical assessment of pulmonary tissue utilizing one animal. Int J Clin Exp Pathol (2011) 0.95

Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Thorax (2007) 0.94

The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am J Respir Cell Mol Biol (2009) 0.93

Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy. Treat Respir Med (2006) 0.90

Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis. J Inflamm Res (2013) 0.89

Transbronchial lung biopsy in diffuse parenchymal lung disease - Question still remains whether to go for surgical lung biopsy or not? Lung India (2016) 0.88

Is there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise. BMC Pulm Med (2007) 0.87

Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease. Int J Rheumatol (2011) 0.87

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. Multidiscip Respir Med (2012) 0.87

Nonspecific interstitial pneumonia-nobody said it's perfect. Am J Respir Crit Care Med (2001) 0.86

Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis. PLoS One (2013) 0.85

Histological evolution of pleuroparenchymal fibroelastosis. Histopathology (2014) 0.85

The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis. Respir Res (2013) 0.85

Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate. Thorax (2007) 0.85

CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis. J Inflamm (Lond) (2007) 0.85

Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective. Proc Am Thorac Soc (2007) 0.84

Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis. Clin Exp Immunol (2011) 0.84

Usual interstitial pneumonia and non-specific interstitial pneumonia: serial thin-section CT findings correlated with pulmonary function. Korean J Radiol (2005) 0.84

mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice. Toxicol Sci (2014) 0.84

A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol Med (2003) 0.83

Idiopathic pulmonary fibrosis: early detection and referral. Respir Med (2014) 0.82

Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS One (2013) 0.81

Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders. Rheumatol Int (2005) 0.81

MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study. Int J Mol Sci (2013) 0.81

Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression. BMC Pulm Med (2010) 0.81

Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique. Adv Ther (2015) 0.81

Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis. Lung (2010) 0.80

Approach to acute exacerbation of idiopathic pulmonary fibrosis. Ann Thorac Med (2013) 0.79

Usual interstitial pneumonia coexisted with nonspecific interstitial pneumonia, What's the diagnosis? Diagn Pathol (2012) 0.78

Diffuse interstitial lung disease: overlaps and uncertainties. Eur Radiol (2010) 0.78

VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis. Cell Signal (2015) 0.78

Idiopathic pulmonary fibrosis: the need for early diagnosis. Multidiscip Respir Med (2013) 0.77

Bone Marrow-Derived Cells in the Pathogenesis of Lung Fibrosis. Curr Respir Med Rev (1) 0.76

VATS biopsy for undetermined interstitial lung disease under non-general anesthesia: comparison between uniportal approach under intercostal block vs. three-ports in epidural anesthesia. J Thorac Dis (2014) 0.76

Utility of Transbronchial versus Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease. Chest (2016) 0.75

Ultrasound in Rheumatologic Interstitial Lung Disease: A Case Report of Nonspecific Interstitial Pneumonia in Rheumatoid Arthritis. Case Rep Rheumatol (2015) 0.75

Relationship between gene expression and lung function in Idiopathic Interstitial Pneumonias. BMC Genomics (2015) 0.75

Fibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease. Curr Respir Med Rev (2013) 0.75

Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibody. Sci Rep (2017) 0.75

CT analysis of the anterior mediastinum in idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Korean J Radiol (2006) 0.75

Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults". Lung (2013) 0.75

Microscopic organizing pneumonia and cellular non-specific interstitial pneumonia are widespread in macroscopically normal-appearing lung tissue in idiopathic pulmonary fibrosis. J Heart Lung Transplant (2016) 0.75

Familial interstitial lung disease in four members of one family: a case series. Cases J (2009) 0.75

Role of Transbronchial Lung Cryobiopsies in Diffuse Parenchymal Lung Diseases: Interest of a Sequential Approach. Pulm Med (2017) 0.75

Nonspecific Interstitial pneumonia (NSIP)/ Overlap or Distinct Entity: A case report from the National Research Institute of Tuberculosis and Lung Disease (NRITLD). Caspian J Intern Med (2014) 0.75

[Pulmonary fibrosis. Classification, diagnosis, therapy]. Internist (Berl) (2003) 0.75

Diagnosis of Idiopathic Pulmonary Fibrosis "Pragmatic Challenges in Clinical Practice". Front Med (Lausanne) (2017) 0.75

Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjogren's syndrome. Virchows Arch (2004) 0.75

Antiinflammation and Antioxidant Effects of Thalidomide on Pulmonary Fibrosis in Mice and Human Lung Fibroblasts. Inflammation (2017) 0.75

Pulmonary complications in human T-cell lymphotropic virus type 1 carriers with Sjögren's syndrome, three case reports and literature review. Rheumatol Int (2009) 0.75

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med (1992) 13.29

Kidney transplantation under FK 506. JAMA (1990) 7.45

The new World Health Organization classification of lung tumours. Eur Respir J (2001) 6.91

Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38

Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest (1990) 5.21

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A (1991) 4.61

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med (2001) 4.45

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg (1995) 4.17

Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol (1980) 4.00

Pulmonary Langerhans'-cell histiocytosis. N Engl J Med (2000) 3.83

Bronchiolitis obliterans organizing pneumonia. N Engl J Med (1985) 3.78

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun (1988) 3.63

Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection. Infect Immun (1989) 3.18

Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus. Cancer Genet Cytogenet (1984) 3.17

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med (2001) 2.94

Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83

Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med (1990) 2.76

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest (1999) 2.65

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63

Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54

Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun (1997) 2.54

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS (2001) 2.47

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest (1998) 2.47

CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol (2000) 2.43

Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med (1998) 2.43

Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer (1994) 2.43

Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem (1989) 2.43

Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1997) 2.42

The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol (1997) 2.41

Follicular bronchitis/bronchiolitis. Hum Pathol (1985) 2.40

Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39

Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest (2001) 2.39

The importance of root gravitropism for inter-root competition and phosphorus acquisition efficiency: results from a geometric simulation model. Plant Soil (2000) 2.39

Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol (2001) 2.38

The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol (1995) 2.37

Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med (2001) 2.35

A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol (2000) 2.35

Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis (1991) 2.34

The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31

Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med (2000) 2.30

Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol (1990) 2.28

Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest (1998) 2.27

Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT. Chest (2001) 2.26

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26

Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology (1991) 2.25

Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J (1998) 2.23

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22

Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg (1996) 2.21

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology (2001) 2.20

Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol (1997) 2.19

Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19

Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J (2009) 2.18

Metastatic mature teratoma in lung following testicular embryonal carcinoma and teratocarcinoma. Arch Pathol Lab Med (1993) 2.16

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12

Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol (1996) 2.12

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10